Pentapeptide-18 (Leuphasyl)

Pentapeptide-18 (Leuphasyl) is a synthetic cosmetic peptide that modulates neurotransmitter release at the neuromuscular junction, functioning as a safer alternative to botulinum toxin for reducing expression lines. The peptide mimics the activity of enkephalins, binding to opioid receptors on muscle cells and reducing acetylcholine release, thereby decreasing muscle contraction intensity. This "Botox-like" mechanism relaxes facial muscles without paralysis, softening dynamic wrinkles particularly in the forehead and around the eyes. Research demonstrates dose-dependent reduction in muscle cell activity in vitro. Clinical studies show improvements in wrinkle depth and skin smoothness when applied topically in appropriate cosmetic formulations. Unlike botulinum toxin injections, Pentapeptide-18 works gradually and subtly with continued use. The peptide is typically combined with other anti-aging ingredients for enhanced effects. It is considered safe for cosmetic use with no significant adverse effects. Leuphasyl provides a non-invasive option for consumers seeking wrinkle reduction without medical procedures.

Pentapeptide-18 is a cosmetic ingredient with no published randomized clinical trials of wrinkle reduction located in this review. The muscle-relaxation mechanism is demonstrated mainly in laboratory assays and manufacturer studies, and cosmetic claims are not FDA-reviewed.

Applied topically in cosmetic formulations; acts locally as an enkephalin-like pentapeptide proposed to reduce muscle contraction at the neuromuscular junction. No systemic pharmacokinetics are relevant for topical cosmetic use.